NCT06250608 (fNIRS) is a NA clinical trial of Pulse oximeter, NIRSITX in Acute Ischemic Stroke Patients, sponsored by OBELAB, Inc..

Who is sponsoring NCT06250608?

NCT06250608 is sponsored by OBELAB, Inc..

What drugs are being tested in NCT06250608?

Interventions in NCT06250608: Pulse oximeter, NIRSITX.

What condition does NCT06250608 study?

NCT06250608 studies Acute Ischemic Stroke Patients.

Is NCT06250608 still recruiting?

NCT06250608 is currently active, enrolled. Last updated 7 January 2026.

Last reviewed 2026-01-07 · How we verify

NCT06250608: fNIRS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of rSO2 Between Frontal Lesion Area and Normal Area of Brain by NIRSITX Using NIRS in Acute Ischemic Stroke Patients.

Active, enrolled NA Last updated 7 January 2026

What this trial tests

NA trial testing Pulse oximeter, NIRSITX in Acute Ischemic Stroke Patients in 35 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

15 March 2024

Primary endpoint
27 December 2025

31 March 2026

Quick facts

Lead sponsor	OBELAB, Inc.
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	screening
Enrollment	35
Start date	15 March 2024
Primary completion	27 December 2025
Estimated completion	31 March 2026
Sites	2 locations across South Korea

Drugs / interventions tested

Pulse oximeter, NIRSITX

Conditions studied

Acute Ischemic Stroke Patients — all drugs for Acute Ischemic Stroke Patients →

Sponsor

OBELAB, Inc.

Who can join

19 and older, any sex, with Acute Ischemic Stroke Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The clinical trial is for acute ischemic stroke patients measuring cerebral oxygen saturation (rSO2) values using pulse oximeter of near-infrared spectroscopy in the frontal lesion area and normal area of brain. The purpose of the clinical trial is to compare differences in cerebral oxygen saturation values, and the efficacy and safety are evaluated through additional exploratory clinical trials.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Acute Ischemic Stroke Patients

Currently open trials in the same condition.

NCT07294209 — Low-Dose Tenecteplase for Acute Ischemic Stroke Treatment in Aging Patients · Phase 4 · recruiting
NCT07001267 — Prospective Randomized Observer Blinded Single Center Study Comparing 90-day Functional Outcome in Patients Who Received · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06250608 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by OBELAB, Inc.
Last refreshed: 7 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06250608.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing